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To the Editor: In a recent paper by Ujhelyi et al.,1 it is
suggested that the decreased antioxidant capacity of plasma ultra-
filtrate observed after a hemodialysis session is related to the
removal of several protein-bound uremic toxins. Although
the authors must be granted for their well-considered methodo-
logical approach, several objections could be raised.
Firstly, it has been demonstrated recently that p-cresol
largely circulates in the form of its conjugate p-cresyl
sulfate2,3 (and a small fraction of p-cresyl glucuronide). This
is of critical importance for in vitro research. The concentra-
tion of unconjugated p-cresol used by Ujhelyi et al. exceeds
in vivo levels by at least a factor 10. Secondly, the percentage
of deconjugation of phenolic compounds depends on the
used analytical procedure and should be taken into account
when comparing results of different methods. Less complete
deconjugation most probably explains the low reported free
p-cresol levels (Table 1). Thirdly, the authors report normal-
ization of free p-cresol levels following a single hemodialysis
session. This finding is counterintuitive, given the fact that
p-cresol circulates as both free and protein bound, and
contrasts with our experience. Indeed, we observed a
reduction ratio of free p-cresol that is only slightly higher
than the reduction ratio of total p-cresol (Table 1).
Finally, although this paper suggests a protective anti-
oxidative effect from elevated p-cresol concentrations in vitro,
we very recently reported data suggesting a deleterious effect
in vivo. Indeed, higher than average free serum levels of
p-cresol predict mortality in hemodialysis patients.4
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We are grateful to Meijers et al.1 for the comments on the
dialytic removal of several protein-unbound metabolites
that decrease the antioxidant capacity of plasma ultrafil-
trate assessed by heme-mediated low-density lipoprotein
(LDL) oxidation and subsequent endothelial cell reac-
tions.2 The recent results on the limited removal of
p-cresol and its conjugates by hemodialysis3,4 have
utmost importance in further development of detoxifying
methods.
The decreased antioxidant capacity of plasma ultrafil-
trate after hemodialysis was demonstrated to occur as a
consequence of the intradialytic removal of L-ascorbic acid,
bilirubin, 3-indoxyl sulfate, indoxyl-b-D-glucuronide,
p-cresol, phenol, and uric acid.2 Other retention solutes –
L-arginine, creatinine, 2-furoic acid, guanidines (guani-
dine, methylguanidine, b-guanidinopropionic acid,
a-guanidinobutyric acid), hippuric acid, myo-inositol,
oxalic acid, polyamines (spermine, spermidine, putrescine,
Table 1 | Comparison between measured p-cresol levels
Reference
Ujhelyi et al. Martinez et al. De Loor et al.
Debrecen Stanford Leuven
Serum total p-cresol
Healthy volunteers (n) 2.271.9 (4) 1.970.4 (29)
HD patients (n) 24.776.3 (19) 24.375.0 (86)
Detected conjugates (%)
p-Cresyl sulfate 100 95.571.1
p-Cresyl glucuronide 0 3.871.8
Unconjugated BLQ BLQ
Serum unbound p-cresol
Before dialysis (n) 0.6070.43 1.93a 1.8671.27 (7)
After dialysis (n) 0.0870.07 0.86a 1.0970.49 (7)
Reduction ratio
Total p-cresol 0.27 0.26 (7)
Free p-cresolb 0.87 0.55 0.41 (7)
BLQ, below limit of quantification; HD, hemodialysis.
All reported data were calculated towards corresponding concentrations of p-cresol
(mg/l).
aValues were calculated from reported percentages of mean values.
bFree p-cresol reduction ratios were estimated by calculation from reported means.
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and cadaverine), purines (xanthine, hypoxanthine), pyri-
midine derivatives (cytidine, orotic acid, thymine, pseudo-
uridine), and trimethylamine – exhibited no protection
against oxidative modification of LDL. In order to compare
the effect of various plasma constituents on the kinetics of
LDL oxidation, we determined the kinetic parameters at
10 lmol/l concentration. Importantly, as shown in Figure 1,
free p-cresol provides protection against LDL oxidation at
concentrations found in chronic kidney disease patients as
well. However, we agree that p-cresol can be responsible
only for a minor part of total antioxidant capacity of
plasma ultrafiltrate. The antioxidant potential of plasma
ultrafiltrate of different individuals correlated with their
absorption between 260 and 290 nm characteristic of the
aromatic ring. As we tested the representative metabolites
of this type accumulated in chronic kidney disease,
conjugated indol derivatives retained absorptive and
protective properties against oxidation of LDL. We agree,
however, that conjugates of p-cresol may have minor
differences with respect to the effect on LDL oxidation.
One of the main differences between the analytical
methods used by us and Meijers et al. is the cutoff limit of
filter to obtain plasma ultrafiltrate (5000 vs. 30 000 Da,
respectively). We suppose that higher molecular weight
compounds present in the ultrafiltrate may alter p-cresol
concentration in the samples obtained either before or
after a single hemodialysis treatment. Nevertheless, use of
molecular weight limit of 5000 Da guaranteed that all
effective compounds were in free form in the ultrafiltrate
of our samples.
Finally, p-cresol can be considered to be a Janus-faced
compound with several toxic5,6 and some beneficial
properties,2,7 and it might be a marker of pathologic
metabolic processes that lead to the observed enhanced
risk of mortality in hemodialysis patients.8
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Figure 1 | Dose-dependent effect of p-cresol on oxidative
resistance of LDL. Degradation of heme was followed
spectrophotometrically during oxidation of LDL in a reaction
mixture containing LDL (200mg/ml), heme (5 mmol/l), and
hydrogen-peroxide (75 mmol/l) in the absence or presence of
p-cresol (0–4 mmol/l). Oxidative resistance of LDL (DT at Vmax) is
expressed as percent of control (mean7s.e., *Po0.05).
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